Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;13(4):150-158.
doi: 10.6705/j.jacme.202312_13(4).0003.

The Role of Procalcitonin/Albumin Ratio and CRP/Albumin Ratio in Predicting In-hospital Mortality in COVID-19 Patients

Affiliations

The Role of Procalcitonin/Albumin Ratio and CRP/Albumin Ratio in Predicting In-hospital Mortality in COVID-19 Patients

Mustafa Kürşat Ayrancı et al. J Acute Med. 2023 Dec.

Abstract

Background: Hospitalized coronavirus disease 2019 (COVID-19) patients have higher mortality rates. Parameters to predict mortality are needed. Therefore, we investigated the power of procalcitonin/albumin ratio (PAR) and C-reactive protein/albumin ratio (CAR) to predict in-hospital mortality in hospitalized COVID-19 patients.

Methods: In this study, 855 patients were included. Patients' PAR and CAR values were recorded from the hospital information management system. The patients were evaluated in two groups according to their in-hospital mortality status.

Results: In-hospital mortality was observed in 163 patients (19.1%). The median PAR and CAR values of patients in the non-survivor group were statistically significantly higher than those of patients in the survivor group, PAR (median: 0.07, interquartile range [IQR]: 0.03-0.33 vs. median: 0.02, IQR: 0.01-0.04, respectively; p < 0.001); CAR (median: 27.60, IQR: 12.49-44.91 vs. median: 7.47, IQR: 2.66-18.93, respectively; p < 0.001). The area under the curve (AUC) and odds ratio (OR) values obtained by PAR to predict in-hospital mortality were higher than the values obtained by procalcitonin, CAR, albumin, and CRP (AUCs of PAR, procalcitonin, CAR, albumin, and CRP: 0.804, 0.792, 0.762, 0.755, and 0.748, respectively; OR: PAR > 0.04, procalcitonin > 0.14, CAR > 20.59, albumin < 4.02, and CRP > 63; 8.215, 7.134, 5.842, 6.073, and 5.07, respectively). Patients with concurrent PAR > 0.04 and CAR > 20.59 had an OR of 15.681 compared to patients with concurrent PAR < 0.04 and CAR < 20.59.

Conclusions: In this study, PAR was found to be more valuable for predicting in-hospital COVID-19 mortality than all other parameters. In addition, concurrent high levels of PAR and CAR were found to be more valuable than a high level of PAR or CAR alone.

Keywords: C-reactive protein; COVID-19; albumins; in-hospital mortality; procalcitonin.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow chart of the study.
Figure 2
Figure 2. Receiver operating characteristic (ROC) curve by in-hospital mortality.
CAR: C-reactive protein/albumin ratio; CRP: C-reactive protein; PAR: procalcitonin/albumin ratio.

References

    1. Su Shuo, Wong Gary, Shi Weifeng, Liu Jun, Lai Alexander C.K., Zhou Jiyong, Liu Wenjun, Bi Yuhai, Gao George F. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses Trends in Microbiology. 2016 Jun;24(6) doi: 10.1016/j.tim.2016.03.003. - DOI - PMC - PubMed
    1. Zhong NS, Zheng BJ, Li YM, Poon LLM, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, Liu XQ, Xu J, Li DX, Yuen KY, Peiris JSM, Guan Y. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003 The Lancet. 2003 Oct;362(9393) doi: 10.1016/s0140-6736(03)14630-2. - DOI - PMC - PubMed
    1. Zaki Ali M., van Boheemen Sander, Bestebroer Theo M., Osterhaus Albert D.M.E., Fouchier Ron A.M. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia New England Journal of Medicine. 2012 Nov 08;367(19) doi: 10.1056/nejmoa1211721. - DOI - PubMed
    1. Arslan Şenol, Delice Orhan, Kahraman Mustafa, Yılmaz Sibel İba, Aslan Mehtap Hülya. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in Turkey Annals of Clinical and Analytical Medicine. 2021 May 01;12(05) doi: 10.4328/acam.20310. - DOI
    1. Inglesby Thomas V. Public Health Measures and the Reproduction Number of SARS-CoV-2 JAMA. 2020 Jun 02;323(21) doi: 10.1001/jama.2020.7878. - DOI - PubMed

LinkOut - more resources